Institute of Parasitology and Biomedicine López-Neyra IPBLN/CSIC

The Spanish National Research Council (CSIC) is one of the leading research organizations in the European Union, playing a key role in science and technology policy in Spain and worldwide, with internationalization as an essential part of its mission.

A key player in the development of the European Research Area (ERA), the CSIC is highly involved in the development and implementation of policies and initiatives within the European Union's research and innovation sector.

Thus, the CSIC maintains a constant presence within the EU through its Delegation to the EU in Brussels and through its participation in associations and organizations that defend its interests, such as Science Europe, the "G6 of Science," and other thematic associations and organizations of which it is a member. Access

As part of its active participation in EU policies and initiatives, the CSIC promotes participation in European Union public consultations. This is achieved by disseminating information about these consultations to all CSIC staff so they can complete them individually, and by compiling and submitting the institutional response when, due to the topic or scope of the consultation, an institutional response is deemed appropriate.

Another key aspect of the CSIC's presence within the EU is through the participation of its staff as experts:

-On committees or expert groups of the European Commission, or on advisory committees of other EU bodies, institutions, or agencies, or of EU-level associations, both individually and representing the institution or even Spain.

-Through participation in the program of Seconded National Experts in the institutions of the European Union.

The Institute of Parasitology and Biomedicine ‘López-Neyra’ (IPBLN), within the Spanish National Research Council (CSIC), focuses on biomedical research in immunology, molecular and cell biology, and pharmacology of diseases with global health impact.

Located at the Granada Health Technology Park (PTS), the IPBLN benefits from an environment that fosters collaboration across academia, industry, and healthcare sectors. It is organized into three departments: Cellular Biology & Immunology, Molecular Biology, and Biochemistry & Molecular Pharmacology.

IPBLN's research aims to understand biomedical processes, particularly in molecular parasitology, immunology, cancer and degenerative disorders, as well as the genetic background of these conditions and the development of new diagnostic and therapeutic tools. Focus areas include autoimmune diseases (e.g., rheumatoid arthritis, lupus, Crohn’s disease), neurodegenerative disorders (e.g., Parkinson’s, multiple sclerosis), infectious diseases (e.g., AIDS, hepatitis C, tropical diseases) and cancer (tumour biology, metastasis and anticancer therapies).

The Institute also plays a key educational role through PhD programs, specialization courses, and scientific outreach. It is active in international collaboration, especially with European and Latin American countries. Additionally, it provides scientific services such as DNA sequencing, proteomics, cytometry, microscopy, bioinformatics, and more.